About
A research supplier that reads the literature before it writes the label.
LONJEVIA operates from Sofia, Bulgaria, supplying research-grade peptides worldwide and publishing compound dossiers written to the standard of the evidence, not the standard of the market.
Principles
Three commitments we hold to
They constrain what we sell, how we describe it, and what we refuse to claim.
Say the tier
Preclinical stays preclinical in our copy, even when it would sell better as something else.
Show the batch
Documentation follows the material. If we cannot evidence a test, we do not mention it.
Refuse the promise
No therapeutic claims, no dosing protocols, no outcome guarantees — ever.